I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR

Wall Street
Price Targets

I4P Price Targets Summary
Intercept Pharmaceuticals Inc

There are no price targets for I4P.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Intercept Pharmaceuticals Inc Competitors:
Price Targets
VLA
Valneva SE
86% Upside
1801
Innovent Biologics Inc
33% Upside
LGND
Ligand Pharmaceuticals Inc
26% Upside
IVVD
Invivyd Inc
166% Upside
2142
Hbm Holdings Ltd
5% Upside
PHARM
Pharming Group NV
45% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
IPH
Innate Pharma SA
223% Upside

Revenue
Forecast

Revenue Estimate
Intercept Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Intercept Pharmaceuticals Inc's revenue is 90%.

90%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Intercept Pharmaceuticals Inc

Operating Income forecast
is not available for
Intercept Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Intercept Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is I4P's stock price target?
Not Available

I4P doesn't have any price targets made by Wall Street professionals.

Back to Top